Editorial by Bruce Shriver, PhD
The Creation of a Robust Registry of Sarcoma Patients and Biological Resources
CTOS Op Ed: Paul A. Meyers, MD discusses why all of us in the sarcoma community would benefit from the creation of a robust registry of sarcoma patients and biological resources.
Well-differentiated and De-differentiated Retroperitoneal Liposarcoma: A Paradigm for Histology Specific Multimodality Therapy
Kerrington Smith, MD, Guy Lahat, MD, Raphael Pollock, MD, PhD and Dina Lev, MD discuss two distinct surgical and multidisciplinary approaches to managing well differentiated and dedifferentiated liposarcomas.
In this study report, Eva Hernando, PhD describes her ongoing research in microDNA deregulation.
In this experimental plan, Jilong Yang, MD, PhD and Wei Zhang, PhD describe research aimed at determining if the WWOX gene is an important tumor suppressor gene in osteosarcoma.
Gilles Frydman discusses why participatory medicine must be a collaborative driven approach to medicine.